Hypertension Clinical Trials in Wuhan
5 recruitingWuhan, China
Showing 1–5 of 5 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1153 locationsNCT07064473
Recruiting
Phase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
AstraZeneca5,000 enrolled753 locationsNCT06742723
Recruiting
Not Applicable
TIPS With or Without BCAA
SarcopeniaCirrhosisPortal Hypertension Related to Cirrhosis+2 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology164 enrolled1 locationNCT07281846
Recruiting
National Registry and Cohort Study of Pulmonary Vascular Disease
Pulmonary Arterial Hypertension
Nanjing First Hospital, Nanjing Medical University1,000 enrolled13 locationsNCT05368467
Recruiting
Phase 3
A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China
Open Angle GlaucomaOcular Hypertension
Santen Pharmaceutical Co., Ltd.338 enrolled25 locationsNCT06666855